Clinical Stage III Cutaneous Melanoma AJCC v8 · Фаза 2 · NCT05136196
Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate, Computed Tomography
National Cancer Institute (NCI) · Open the brief
Melanoma · Фаза 2 · NCT05428007
Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab
NYU Langone Health · Open the brief
Metastatic Melanoma · Фаза 2 · NCT05155033
Pembrolizumab, Aldesleukin
National Cancer Institute (NCI) · Open the brief
Advanced Melanoma · Фаза 2 · NCT06594991
Fianlimab, Cemiplimab, Ipilimumab
Memorial Sloan Kettering Cancer Center · Open the brief
Melanoma (Skin Cancer) · Фаза 2 · NCT07740941
Pembrolizumab, Ipilimumab plus nivolumab
UNC Lineberger Comprehensive Cancer Center · Open the brief
Malignant Melanoma · Фаза 2 · NCT06961006
Intismeran autogene, Pembrolizumab, Placebo
Merck Sharp & Dohme LLC · Open the brief
Merkel Cell Carcinoma · Фаза 2 · NCT05583708
Pembrolizumab, Lutetium Lu 177 dotatate
Weill Medical College of Cornell University · Open the brief
Acral Lentiginous Melanoma · Фаза 2 · NCT04511013
Binimetinib, Encorafenib, Ipilimumab, Nivolumab
SWOG Cancer Research Network · Open the brief
Sinonasal Melanoma · Фаза 2 · NCT05546827
Surgical resection
M.D. Anderson Cancer Center · Open the brief
Uveal Melanoma · Фаза 2 · NCT06070012
Tebentafusp
Diwakar Davar · Open the brief
Melanoma Stage III · Фаза 2 · NCT06284590
L19IL2, L19TNF, L19IL2/L19TNF, KEYTRUDA®
Philogen S.p.A. · Open the brief
Metastatic Melanoma · Фаза 2 · NCT05779423
Ipilimumab, Nivolumab, Cryoablation
Massachusetts General Hospital · Open the brief
Mucosal Melanoma of the Head and Neck · Фаза 2 · NCT04318717
Pembrolizumab, Hypofractionated radiation therapy
Washington University School of Medicine · Open the brief
Cutaneous Angiosarcoma · Фаза 2 · NCT07655570
Ivonescimab
M.D. Anderson Cancer Center · Open the brief
Metastatic Melanoma · Фаза 2 · NCT07504796
Nivolumab, Relatlimab, Ipilimumab, Signatera genome MRD assay
NYU Langone Health · Open the brief
Melanoma · Фаза 2 · NCT02621021 · Papers
young TIL, Pembrolizumab, Aldesleukin, Fludarabine
National Cancer Institute (NCI) · Open the brief
Melanoma Stage III · Фаза 2 · NCT04598009
Binimetinib, Imatinib
University of California, San Francisco · Open the brief
Melanoma · Фаза 2 · NCT04594187
Immunotherapy, Quality-of-Life Assessment, Radiation Therapy
M.D. Anderson Cancer Center · Open the brief
Locally Advanced Cutaneous Squamous Cell Carcinoma · Фаза 2 · NCT07228442
L19IL2/L19TNF
Philogen S.p.A. · Open the brief
Locally Advanced Basal Cell Carcinoma · Фаза 2 · NCT07227870
L19IL2/L19TNF
Philogen S.p.A. · Open the brief
Merkel Cell Carcinoma · Фаза 2 · NCT05100095
Radiation therapy
M.D. Anderson Cancer Center · Open the brief
Melanoma · Фаза 2 · NCT04114136 · Papers
Nivolumab or Pembrolizumab (dependent upon approved indication), Metformin, Rosiglitazone
Dan Zandberg · Open the brief
Uveal Melanoma · Фаза 2 · NCT06932757
Quisinostat
University of Miami · Open the brief
Locally Advanced Unresectable Uveal Melanoma · Фаза 2 · NCT06414590
Tebentafusp-Tebn
Thomas Jefferson University · Open the brief